法國Novasep
Novasep 開發、銷售和應用創新技術,為生命科學行業提供安全且具成本效益的活性分子生產工藝。 Novasep 提供的全球制造解決方案包括工藝開發服務;凈化設備和系統;合約制造服務及復雜的活性分子。 Novasep 的產品應用于醫藥、生物制藥、食品、功能性成份及生物行業市場。
本公司在法國、德國和巴哈馬設有六間受 FDA 檢查的制造廠,在比利時設有兩間生物醫藥生產地點,在美國、中國和法國設有設備制造設施,在日本設有一間辦事處。本公司擁有大約1,300名員工,2009年的年度收入為3億歐羅。目前有2,000多種 Novasep 設計和生產的系統在全球各地凈化活性分子。本公司擁有超過200項技術和工藝專利。
Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.
In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model:
we develop manufacturing solutions,
we provide custom manufacturing services (outsourcing solutions),
we sell purification processes (in-sourcing solutions).
Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.
We operate through two complementary business divisions, Novasep Process and Novasep Synthesis.
Novasep Synthesis uses a large range of chemical synthesis and purification technologies to develop and produce high value-adding active ingredients and advanced intermediates for the pharmaceutical, crop science and other fine chemical industries.
Novasep Process develops and supplies innovative purification processes, equipment and systems for the pharmaceutical, biopharmaceutical and industrial biotechnology industries and provides contract manufacturing services for biopharmaceuticals.